Common Osteoporosis Medication Linked to Reduced Dementia Risk in New Study
Recent research examining medical records of over 120,000 older adults suggests a potential link between nitrogen-containing bisphosphonates and a lower incidence of dementia.
❤️Conditions & CarePhoto: Women's Health
Key points
- Study analyzed medical records of over 120,000 patients aged 60 and older.
- Users of nitrogen-containing bisphosphonates showed a 24% lower dementia risk compared to those on other osteoporosis drugs.
- Experts stress that further clinical trials are needed to prove direct causation.
A commonly prescribed class of osteoporosis medications known as nitrogen-containing bisphosphonates may offer a secondary benefit for cognitive health, according to an observational study published in the journal Alzheimer’s & Dementia. Researchers at the University of Hong Kong analyzed electronic medical records from more than 120,000 patients aged 60 and older who had osteoporosis or fragility fractures. The findings revealed that individuals using these bone-strengthening drugs experienced a 16 percent lower risk of developing Alzheimer's disease and related dementias compared to untreated peers, and a 24 percent lower risk when compared specifically to patients taking alternative osteoporosis treatments.
What to know: While the data highlights an intriguing correlation, specialists emphasize that this observational study does not prove causation. Experts note that improved bone health allows patients to maintain higher levels of physical activity, which naturally helps protect cognitive function. Additionally, researchers theorize that the medications might influence inflammation or neurodegenerative pathways, though randomized clinical trials are required to confirm these hypotheses.
Physicians do not currently recommend prescribing these drugs solely for dementia prevention. However, study co-author Ching-Lung Cheung, PhD, suggests the findings should reassure patients who need osteoporosis treatment that managing their bone health could potentially offer broader wellness benefits. Readers should consult a qualified healthcare provider for personalized medical decisions regarding treatment plans.
Source Women's Health — womenshealthmag.com/health/a74425105/osteoporosis-drug-dementia-ris… ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.